Biochemical studies on the enzymatic deficiencies in hereditary tyrosinemia
- PMID: 6652907
- DOI: 10.1016/0009-8981(83)90191-2
Biochemical studies on the enzymatic deficiencies in hereditary tyrosinemia
Abstract
Experiments are described on the effects of succinylacetone and fumarylacetoacetate on delta-aminolevulinic acid dehydratase, methionine adenosyltransferase and p-OH-phenylpyruvate dioxygenase. delta-Aminolevulinic acid dehydratase from human erythrocytes is inhibited non-competitively by succinylacetone (Ki 0.03 mumol/l) and by fumarylacetoacetate (Ki 0.06 mumol/l). The inhibition by succinylacetone is not prevented by dithiothreitol, but the inhibition by fumarylacetoacetate is not observed if dithiothreitol is present. Methionine adenosyltransferase, partially purified from rabbit liver, is not inhibited by succinylacetone but is inhibited by fumarylacetoacetate: 69% inhibition is observed at 1 mmol/l. Human liver p-OH-phenylpyruvate dioxygenase is not inhibited by succinylacetone or fumarylacetoacetate. It is concluded that secondary enzyme deficiencies observed in hereditary tyrosinemia (delta-aminolevulinic acid dehydratase, methionine adenosyl transferase) are the result of inhibition by succinylacetone and fumarylacetoacetate, accumulating as a result of a primary deficiency of fumarylacetoacetase.
Similar articles
-
On the enzymic defects in hereditary tyrosinemia.Proc Natl Acad Sci U S A. 1977 Oct;74(10):4641-5. doi: 10.1073/pnas.74.10.4641. Proc Natl Acad Sci U S A. 1977. PMID: 270706 Free PMC article.
-
Hereditary tyrosinemia and the heme biosynthetic pathway. Profound inhibition of delta-aminolevulinic acid dehydratase activity by succinylacetone.J Clin Invest. 1983 Mar;71(3):625-34. doi: 10.1172/jci110809. J Clin Invest. 1983. PMID: 6826727 Free PMC article.
-
Succinylacetone inhibits delta-aminolevulinate dehydratase and potentiates the drug and steroid induction of delta-aminolevulinate synthase in liver.Trans Assoc Am Physicians. 1982;95:42-52. Trans Assoc Am Physicians. 1982. PMID: 7182986
-
Hereditary tyrosinemia type I--an overview.Scand J Clin Lab Invest Suppl. 1986;184:27-34. Scand J Clin Lab Invest Suppl. 1986. PMID: 3296130 Review.
-
[delta-Aminolevulinate dehydratase deficiency].Nihon Rinsho. 1995 Jun;53(6):1408-17. Nihon Rinsho. 1995. PMID: 7616655 Review. Japanese.
Cited by
-
Point mutations in the murine fumarylacetoacetate hydrolase gene: Animal models for the human genetic disorder hereditary tyrosinemia type 1.Proc Natl Acad Sci U S A. 2001 Jan 16;98(2):641-5. doi: 10.1073/pnas.98.2.641. Proc Natl Acad Sci U S A. 2001. PMID: 11209059 Free PMC article.
-
Clinical features and diagnostic approach in type I tyrosinaemia in an infant with cytomegaly virus infection and bacterial sepsis.Eur J Pediatr. 1993 Apr;152(4):327-30. doi: 10.1007/BF01956746. Eur J Pediatr. 1993. PMID: 8387006
-
Tyrosinaemia type 1 and glutathione synthetase deficiency: two disorders with reduced hepatic thiol group concentrations and a liver 4-fumarylacetoacetate hydrolase deficiency.J Inherit Metab Dis. 1995;18(1):48-55. doi: 10.1007/BF00711372. J Inherit Metab Dis. 1995. PMID: 7623442
-
Successful treatment of severe cardiomyopathy with NTBC in a child with tyrosinaemia type I.J Inherit Metab Dis. 2005;28(1):103-6. doi: 10.1007/s10545-005-5085-4. J Inherit Metab Dis. 2005. PMID: 15702412
-
Hereditary tyrosinemia type Ⅰ: newborn screening, diagnosis and treatment.Zhejiang Da Xue Xue Bao Yi Xue Ban. 2021 Aug 25;50(4):514-523. doi: 10.3724/zdxbyxb-2021-0255. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2021. PMID: 34704422 Free PMC article. English.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical